Value of the Free to Total Prostate Specific Antigen Ratio and Prostate Specific Antigen Density for Detecting Prostate Cancer in Japanese Patients
โ Scribed by Hiroshi Maeda; Yoichi Arai; Kazutoshi Okubo; Yoshitaka Aoki; Takashi Okada; Shinya Maekawa
- Book ID
- 108976377
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 521 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0919-8172
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Prostate-specific antigen (PSA) is the most accurate serum marker for cancer of the prostate (CAP). However, its sensitivity and specificity are suboptimal, especially at values ranging between 4.1 and 10.0ng/ml (monoclonal), because benign prostatic hypertrophy and hyperplasia (BPH) and CaP frequen
Background. Prostate specific antigen (PSA) is useful as a tumor marker for monitoring patients with prostate cancer after definitive therapy. Limitations have been noted when PSA was used for the early detection of prostate cancer. The use of prostate specific antigen density [PSAD = PSA (ng/ml)/pr